Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Inflammatory Myofibroblastic Tumor After Lung Transplant-A Rare and Aggressive Complication: A Case Report.

Poggi C, Pecoraro Y, Carillo C, Anile M, Amore D, Mantovani S, Naldi G, Pagini A, Bassi M, Cagnetti S, Mottola E, D'Agostino F, Vannucci J, Pernazza A, Cimino G, Savi D, Gomellini S, Pugliese F, De Giacomo T, Rendina EA, Venuta F, Diso D.

Transplant Proc. 2019 Oct 11. pii: S0041-1345(19)30751-1. doi: 10.1016/j.transproceed.2019.08.011. [Epub ahead of print]

PMID:
31611127
2.

Impact of clonally-related Burkholderia contaminans strains in two patients attending an Italian cystic fibrosis centre: a case report.

Savi D, Quattrucci S, Trancassini M, Dalmastri C, De Biase RV, Maggisano M, Palange P, Bevivino A.

BMC Pulm Med. 2019 Aug 29;19(1):164. doi: 10.1186/s12890-019-0923-6.

3.

Neopestalotiopsis species presenting wide dye destaining activity: report of a mycelium-associated laccase.

Marzall-Pereira M, Savi DC, Bruscato EC, Niebisch CH, Paba J, Aluízio R, Ferreira-Maba LS, Galli-Terasawa LV, Glienke C, Kava V.

Microbiol Res. 2019 Nov;228:126299. doi: 10.1016/j.micres.2019.126299. Epub 2019 Jul 25.

PMID:
31422231
4.

Dihydroisocoumarins produced by Diaporthe cf. heveae LGMF1631 inhibiting citrus pathogens.

Savi DC, Noriler SA, Ponomareva LV, Thorson JS, Rohr J, Glienke C, Shaaban KA.

Folia Microbiol (Praha). 2019 Aug 10. doi: 10.1007/s12223-019-00746-8. [Epub ahead of print]

PMID:
31401763
5.

Vochysiamides A and B: Two new bioactive carboxamides produced by the new species Diaporthe vochysiae.

Noriler SA, Savi DC, Ponomareva LV, Rodrigues R, Rohr J, Thorson JS, Glienke C, Shaaban KA.

Fitoterapia. 2019 Jul 22;138:104273. doi: 10.1016/j.fitote.2019.104273. [Epub ahead of print]

PMID:
31344395
6.

Microscopic analysis of colonization of Colletotrichum abscissum in citrus tissues.

Savi DC, Rossi BJ, Rossi GR, Ferreira-Maba LS, Bini IH, Trindade EDS, Goulin EH, Machado MA, Glienke C.

Microbiol Res. 2019 Sep;226:27-33. doi: 10.1016/j.micres.2019.05.005. Epub 2019 May 28.

PMID:
31284941
7.

Reduced exercise ventilatory efficiency in adults with cystic fibrosis and normal to moderately impaired lung function.

Di Paolo M, Teopompi E, Savi D, Crisafulli E, Longo C, Tzani P, Longo F, Ielpo A, Pisi G, Cimino G, Simmonds NJ, Neder JA, Chetta A, Palange P.

J Appl Physiol (1985). 2019 Aug 1;127(2):501-512. doi: 10.1152/japplphysiol.00030.2019. Epub 2019 Jun 20.

PMID:
31219769
8.

Impact of CFTR-modulating drugs on GH-IGF-1 axis impairment in adult patients with cystic fibrosis.

Pascucci C, De Biase RV, Savi D, Quattrucci S, Gnessi L, Lubrano C, Lenzi A.

J Endocrinol Invest. 2019 Nov;42(11):1361-1363. doi: 10.1007/s40618-019-01051-4. Epub 2019 Apr 20.

PMID:
31006073
9.

Effects of Lumacaftor/Ivacaftor on physical activity and exercise tolerance in three adults with cystic fibrosis.

Savi D, Schiavetto S, Simmonds NJ, Righelli D, Palange P.

J Cyst Fibros. 2019 May;18(3):420-424. doi: 10.1016/j.jcf.2019.03.001. Epub 2019 Mar 14.

PMID:
30879989
10.

ERG11 gene polymorphisms and susceptibility to fluconazole in Candida isolates from diabetic and kidney transplant patients.

Benedetti VP, Savi DC, Aluizio R, Adamoski D, Kava V, Galli-Terasawa LV, Glienke C.

Rev Soc Bras Med Trop. 2019 Mar 7;52:e20180473. doi: 10.1590/0037-8682-0473-2018.

11.

Muscodor brasiliensis sp. nov. produces volatile organic compounds with activity against Penicillium digitatum.

Pena LC, Jungklaus GH, Savi DC, Ferreira-Maba L, Servienski A, Maia BHLNS, Annies V, Galli-Terasawa LV, Glienke C, Kava V.

Microbiol Res. 2019 Apr;221:28-35. doi: 10.1016/j.micres.2019.01.002. Epub 2019 Jan 18.

PMID:
30825939
12.

Secondary metabolites produced by the citrus phytopathogen Phyllosticta citricarpa.

Savi DC, Shaaban KA, Mitra P, Ponomareva LV, Thorson JS, Glienke C, Rohr J.

J Antibiot (Tokyo). 2019 May;72(5):306-310. doi: 10.1038/s41429-019-0154-3. Epub 2019 Feb 21.

PMID:
30792517
13.

Erratum: Brazilian Plants: An Unexplored Source of Endophytes as Producers of Active Metabolites.

Savi DC, Aluizio R, Glienke C.

Planta Med. 2019 Feb 21. doi: 10.1055/a-0861-1595. [Epub ahead of print]

PMID:
30791056
14.

Brazilian Plants: An Unexplored Source of Endophytes as Producers of Active Metabolites.

Savi DC, Aluizio R, Glienke C.

Planta Med. 2019 May;85(8):619-636. doi: 10.1055/a-0847-1532. Epub 2019 Feb 11. Review.

PMID:
30743274
15.

Survival After Lung Transplant for Cystic Fibrosis in Italy: A Single Center Experience With 20 Years of Follow-up.

Savi D, Mordenti M, Bonci E, Troiani P, Giordani B, D'Alù V, Bertasi S, Cimino G, Rossi P, Poggi C, Palange P, Quattrucci S.

Transplant Proc. 2018 Dec;50(10):3732-3738. doi: 10.1016/j.transproceed.2018.08.020. Epub 2018 Sep 7.

PMID:
30577264
16.

Secondary metabolites produced by Microbacterium sp. LGMB471 with antifungal activity against the phytopathogen Phyllosticta citricarpa.

Savi DC, Shaaban KA, Gos FMW, Thorson JS, Glienke C, Rohr J.

Folia Microbiol (Praha). 2019 May;64(3):453-460. doi: 10.1007/s12223-018-00668-x. Epub 2018 Dec 18.

PMID:
30565048
17.

Bioprospecting and Structure of Fungal Endophyte Communities Found in the Brazilian Biomes, Pantanal, and Cerrado.

Noriler SA, Savi DC, Aluizio R, Palácio-Cortes AM, Possiede YM, Glienke C.

Front Microbiol. 2018 Jul 24;9:1526. doi: 10.3389/fmicb.2018.01526. eCollection 2018.

18.

Is daily physical activity affected by dynamic hyperinflation in adults with cystic fibrosis?

Savi D, Di Paolo M, Simmonds NJ, Pascucci C, Quattrucci S, Palange P.

BMC Pulm Med. 2018 Apr 19;18(1):60. doi: 10.1186/s12890-018-0623-7.

19.

Bioprospecting of Diaporthe terebinthifolii LGMF907 for antimicrobial compounds.

de Medeiros AG, Savi DC, Mitra P, Shaaban KA, Jha AK, Thorson JS, Rohr J, Glienke C.

Folia Microbiol (Praha). 2018 Jul;63(4):499-505. doi: 10.1007/s12223-018-0587-2. Epub 2018 Mar 1.

20.

Phaeophleospora vochysiae Savi & Glienke sp. nov. Isolated from Vochysia divergens Found in the Pantanal, Brazil, Produces Bioactive Secondary Metabolites.

Savi DC, Shaaban KA, Gos FMWR, Ponomareva LV, Thorson JS, Glienke C, Rohr J.

Sci Rep. 2018 Feb 15;8(1):3122. doi: 10.1038/s41598-018-21400-2.

21.

CFTR Genotype and Maximal Exercise Capacity in Cystic Fibrosis: A Cross-sectional Study.

Radtke T, Hebestreit H, Gallati S, Schneiderman JE, Braun J, Stevens D, Hulzebos EH, Takken T, Boas SR, Urquhart DS, Lands LC, Tejero S, Sovtic A, Dwyer T, Petrovic M, Harris RA, Karila C, Savi D, Usemann J, Mei-Zahav M, Hatziagorou E, Ratjen F, Kriemler S; CFTR-Exercise study group.

Ann Am Thorac Soc. 2018 Feb;15(2):209-216. doi: 10.1513/AnnalsATS.201707-570OC. Epub 2017 Nov 15.

22.

Deregulation of the growth hormone/insulin-like growth factor-1 axis in adults with cystic fibrosis.

Pascucci C, De Biase RV, Savi D, Quattrucci S, Isidori AM, Lubrano C, Gnessi L, Lenzi A.

J Endocrinol Invest. 2018 May;41(5):591-596. doi: 10.1007/s40618-017-0784-x. Epub 2017 Nov 2.

PMID:
29098662
23.

Antibacterial Activity of Endophytic Actinomycetes Isolated from the Medicinal Plant Vochysia divergens (Pantanal, Brazil).

Gos FMWR, Savi DC, Shaaban KA, Thorson JS, Aluizio R, Possiede YM, Rohr J, Glienke C.

Front Microbiol. 2017 Sep 6;8:1642. doi: 10.3389/fmicb.2017.01642. eCollection 2017.

24.

Physical activity patterns and clusters in 1001 patients with COPD.

Mesquita R, Spina G, Pitta F, Donaire-Gonzalez D, Deering BM, Patel MS, Mitchell KE, Alison J, van Gestel AJ, Zogg S, Gagnon P, Abascal-Bolado B, Vagaggini B, Garcia-Aymerich J, Jenkins SC, Romme EA, Kon SS, Albert PS, Waschki B, Shrikrishna D, Singh SJ, Hopkinson NS, Miedinger D, Benzo RP, Maltais F, Paggiaro P, McKeough ZJ, Polkey MI, Hill K, Man WD, Clarenbach CF, Hernandes NA, Savi D, Wootton S, Furlanetto KC, Cindy Ng LW, Vaes AW, Jenkins C, Eastwood PR, Jarreta D, Kirsten A, Brooks D, Hillman DR, Sant'Anna T, Meijer K, Dürr S, Rutten EP, Kohler M, Probst VS, Tal-Singer R, Gil EG, den Brinker AC, Leuppi JD, Calverley PM, Smeenk FW, Costello RW, Gramm M, Goldstein R, Groenen MT, Magnussen H, Wouters EF, ZuWallack RL, Amft O, Watz H, Spruit MA.

Chron Respir Dis. 2017 Aug;14(3):256-269. doi: 10.1177/1479972316687207. Epub 2017 Feb 24.

25.

Differential colonization by bioprospected rhizobial bacteria associated with common bean in different cropping systems.

de Oliveira-Francesquini JP, Hungria M, Savi DC, Glienke C, Aluizio R, Kava V, Galli-Terasawa LV.

Can J Microbiol. 2017 Aug;63(8):682-689. doi: 10.1139/cjm-2016-0784. Epub 2017 Apr 4.

PMID:
28376308
26.

Biological activity of Diaporthe terebinthifolii extracts against Phyllosticta citricarpa.

Tonial F, Maia BHLNS, Sobottka AM, Savi DC, Vicente VA, Gomes RR, Glienke C.

FEMS Microbiol Lett. 2017 Mar 1;364(5). doi: 10.1093/femsle/fnx026.

PMID:
28158748
27.

Identification of genes associated with asexual reproduction in Phyllosticta citricarpa mutants obtained through Agrobacterium tumefaciens transformation.

Goulin EH, Savi DC, Petters DAL, Kava V, Galli-Terasawa L, Silva GJ Jr, Glienke C.

Microbiol Res. 2016 Nov;192:142-147. doi: 10.1016/j.micres.2016.06.010. Epub 2016 Jun 27.

28.

Analysis of the genetic diversity of Candida isolates obtained from diabetic patients and kidney transplant recipients.

Benedetti VP, Savi DC, Aluizio R, Adamoski D, Kava-Cordeiro V, Galli-Terasawa LV, Glienke C.

Mem Inst Oswaldo Cruz. 2016 Jun 7;0:0. doi: 10.1590/0074-02760160042.

29.

Diaporthe endophytica and D. terebinthifolii from medicinal plants for biological control of Phyllosticta citricarpa.

Santos PJ, Savi DC, Gomes RR, Goulin EH, Da Costa Senkiv C, Tanaka FA, Almeida ÁM, Galli-Terasawa L, Kava V, Glienke C.

Microbiol Res. 2016 May-Jun;186-187:153-60. doi: 10.1016/j.micres.2016.04.002. Epub 2016 Apr 9.

30.

16S-gyrB-rpoB multilocus sequence analysis for species identification in the genus Microbispora.

Savi DC, Aluizio R, Galli-Terasawa L, Kava V, Glienke C.

Antonie Van Leeuwenhoek. 2016 Jun;109(6):801-15. doi: 10.1007/s10482-016-0680-y. Epub 2016 Mar 17.

PMID:
26984252
31.

Relationship between pulmonary exacerbations and daily physical activity in adults with cystic fibrosis.

Savi D, Simmonds N, Di Paolo M, Quattrucci S, Palange P, Banya W, Hopkinson NS, Bilton D.

BMC Pulm Med. 2015 Dec 1;15:151. doi: 10.1186/s12890-015-0151-7.

32.

Influence of Culturing Conditions on Bioprospecting and the Antimicrobial Potential of Endophytic Fungi from Schinus terebinthifolius.

Tonial F, Maia BHLNS, Gomes-Figueiredo JA, Sobottka AM, Bertol CD, Nepel A, Savi DC, Vicente VA, Gomes RR, Glienke C.

Curr Microbiol. 2016 Feb;72(2):173-183. doi: 10.1007/s00284-015-0929-0. Epub 2015 Nov 13.

PMID:
26563302
33.

Relationship between daily physical activity and aerobic fitness in adults with cystic fibrosis.

Savi D, Di Paolo M, Simmonds N, Onorati P, Internullo M, Quattrucci S, Winston B, Laveneziana P, Palange P.

BMC Pulm Med. 2015 May 9;15:59. doi: 10.1186/s12890-015-0036-9.

34.

Microbispora sp. LGMB259 endophytic actinomycete isolated from Vochysia divergens (Pantanal, Brazil) producing β-carbolines and indoles with biological activity.

Savi DC, Shaaban KA, Vargas N, Ponomareva LV, Possiede YM, Thorson JS, Glienke C, Rohr J.

Curr Microbiol. 2015 Mar;70(3):345-54. doi: 10.1007/s00284-014-0724-3. Epub 2014 Nov 11.

35.

Burkholderia pyrrocinia in cystic fibrosis lung transplantation: a case report.

Savi D, De Biase RV, Amaddeo A, Anile M, Venuta F, Ruberto F, Simmonds N, Cimino G, Quattrucci S.

Transplant Proc. 2014 Jan-Feb;46(1):295-7. doi: 10.1016/j.transproceed.2013.08.108.

PMID:
24507071
36.

Lung clearance index: evidence for use in clinical trials in cystic fibrosis.

Kent L, Reix P, Innes JA, Zielen S, Le Bourgeois M, Braggion C, Lever S, Arets HG, Brownlee K, Bradley JM, Bayfield K, O'Neill K, Savi D, Bilton D, Lindblad A, Davies JC, Sermet I, De Boeck K; European Cystic Fibrosis Society Clinical Trial Network (ECFS-CTN) Standardisation Committee.

J Cyst Fibros. 2014 Mar;13(2):123-38. doi: 10.1016/j.jcf.2013.09.005. Epub 2013 Dec 5. Review.

37.

Measuring habitual physical activity in adults with cystic fibrosis.

Savi D, Quattrucci S, Internullo M, De Biase RV, Calverley PM, Palange P.

Respir Med. 2013 Dec;107(12):1888-94. doi: 10.1016/j.rmed.2013.09.012. Epub 2013 Sep 22.

38.

Clinical effects of diet supplementation with DHA in pediatric patients suffering from cystic fibrosis.

Leggieri E, De Biase RV, Savi D, Zullo S, Halili I, Quattrucci S.

Minerva Pediatr. 2013 Aug;65(4):389-98.

PMID:
24051972
39.

Depollution benchmarks for capacitors, batteries and printed wiring boards from waste electrical and electronic equipment (WEEE).

Savi D, Kasser U, Ott T.

Waste Manag. 2013 Dec;33(12):2737-43. doi: 10.1016/j.wasman.2013.08.014. Epub 2013 Sep 11.

PMID:
24035727
40.

Genital schistosomiasis mansoni: tubal tumor and parietal peritoneum involvement diagnosed during laparoscopy.

Lambertucci JR, Villamil QT, Savi D, Dias IC.

Rev Soc Bras Med Trop. 2009 Sep-Oct;42(5):583-6.

41.

Bone marrow-derived progenitors are greatly reduced in patients with severe COPD and low-BMI.

Huertas A, Testa U, Riccioni R, Petrucci E, Riti V, Savi D, Serra P, Bonsignore MR, Palange P.

Respir Physiol Neurobiol. 2010 Jan 31;170(1):23-31. doi: 10.1016/j.resp.2009.10.003. Epub 2009 Nov 4.

PMID:
19895908
42.

[Training and standardized criteria improve the diagnosis of premalignant breast lesions].

Salles Mde A, Gouvêa AP, Savi D, Figueiredo MA, Tavares Neto R, Paula RA, Gobbi H.

Rev Bras Ginecol Obstet. 2008 Nov;30(11):550-5. Portuguese.

PMID:
19148432
43.

Clinical use of Heliox in asthma and COPD.

Valli G, Paoletti P, Savi D, Martolini D, Palange P.

Monaldi Arch Chest Dis. 2007 Sep;67(3):159-64. Review.

PMID:
18018756

Supplemental Content

Support Center